Subclinical leaflet thrombus in patients with severe aortic stenosis and atrial fibrillation -ENRICH-AF TAVI study
Yasuhiro Otsuka, Masanobu Ishii, Noriaki Tabata, Seitaro Oda, Masafumi Kidoh, Yuichiro Shirahama, Koichi Egashira, Naoto Kuyama, Taku Rokutanda, Katsuo Noda, Eiji Horio, Tomohiro Sakamoto, Takashi Kudo, Hideki Shimomura, Tomokazu Ikemoto, Ryusuke Tsunoda, Taishi Nakamura

TL;DR
This study investigates subclinical leaflet thrombus formation in patients with severe aortic stenosis and atrial fibrillation after TAVI, using imaging and fluid dynamics.
Contribution
The study provides new insights into the acute formation and resolution of subclinical leaflet thrombus after TAVI using novel thrombogenicity and flow analysis methods.
Findings
Subclinical leaflet thrombus was observed in 16.7% of patients at 1 week but decreased to 5.9% at 3 months after TAVI.
Thrombogenicity decreased significantly at 1 week and showed a tendency to increase at 3 months.
Flow stagnation volume was positively associated with increased leaflet thickness.
Abstract
Subclinical leaflet thrombosis (SLT) can be one of the causes of transcatheter heart valve (THV) failure after transcatheter aortic valve implantation (TAVI). We sought to clarify the formation process of SLT and thrombogenicity during the perioperative period of TAVI. This multicenter, prospective, single-arm interventional study enrolled 26 patients treated with edoxaban for atrial fibrillation and who underwent TAVI for severe aortic stenosis between September 2018 and September 2022. We investigated changes in maximal leaflet thickness detected by contrast-enhanced computed tomography between 1 week and 3 months after TAVI in 18 patients and measured the thrombogenicity by Total Thrombus-formation Analysis System (T-TAS) and flow stagnation volume by computational fluid dynamics (CFD) (n = 11). SLT was observed in 16.7% (3/18) at 1 week, but decreased to 5.9% (1/17) at 3 months…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAtrial Fibrillation Management and Outcomes · Cardiac Valve Diseases and Treatments · Cardiac Imaging and Diagnostics
